MESSA, PIERGIORGIO
 Distribuzione geografica
Continente #
NA - Nord America 9380
EU - Europa 8482
AS - Asia 4201
SA - Sud America 224
OC - Oceania 122
AF - Africa 89
Continente sconosciuto - Info sul continente non disponibili 16
Totale 22514
Nazione #
US - Stati Uniti d'America 8995
GB - Regno Unito 4164
CN - Cina 2630
IT - Italia 1485
SE - Svezia 933
DE - Germania 690
JP - Giappone 246
CA - Canada 227
IN - India 219
VN - Vietnam 216
TR - Turchia 169
DK - Danimarca 167
KR - Corea 157
UA - Ucraina 157
FR - Francia 140
TW - Taiwan 131
MX - Messico 126
ES - Italia 113
AU - Australia 106
RU - Federazione Russa 105
NL - Olanda 86
BR - Brasile 83
IR - Iran 65
HK - Hong Kong 64
EU - Europa 62
ID - Indonesia 61
FI - Finlandia 57
CH - Svizzera 56
CO - Colombia 50
GR - Grecia 50
BE - Belgio 47
PL - Polonia 42
EG - Egitto 39
TH - Thailandia 36
MY - Malesia 35
RO - Romania 35
AR - Argentina 30
PK - Pakistan 28
PT - Portogallo 28
CL - Cile 24
PE - Perù 22
RS - Serbia 22
IL - Israele 19
IE - Irlanda 18
NZ - Nuova Zelanda 16
PH - Filippine 16
AT - Austria 13
HN - Honduras 13
SA - Arabia Saudita 13
SG - Singapore 13
NO - Norvegia 12
IQ - Iraq 11
NG - Nigeria 11
GT - Guatemala 10
HR - Croazia 9
MA - Marocco 9
OM - Oman 9
SI - Slovenia 9
CY - Cipro 8
LK - Sri Lanka 8
NP - Nepal 8
HU - Ungheria 7
LB - Libano 7
LT - Lituania 7
SD - Sudan 7
BO - Bolivia 6
CZ - Repubblica Ceca 6
MK - Macedonia 6
KE - Kenya 5
KW - Kuwait 5
BA - Bosnia-Erzegovina 4
CU - Cuba 4
UZ - Uzbekistan 4
VE - Venezuela 4
ZA - Sudafrica 4
BD - Bangladesh 3
BY - Bielorussia 3
EC - Ecuador 3
ET - Etiopia 3
IS - Islanda 3
JO - Giordania 3
KZ - Kazakistan 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AP - ???statistics.table.value.countryCode.AP??? 2
BG - Bulgaria 2
BH - Bahrain 2
DZ - Algeria 2
LA - Repubblica Popolare Democratica del Laos 2
MT - Malta 2
PA - Panama 2
QA - Qatar 2
SC - Seychelles 2
UG - Uganda 2
AL - Albania 1
BJ - Benin 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
Totale 22554
Città #
Southend 3859
Fairfield 1204
Houston 992
Princeton 697
Seattle 600
Wilmington 570
Woodbridge 566
Milan 530
Redwood City 501
Ann Arbor 471
Ashburn 469
Nanjing 426
Cambridge 388
Beijing 363
Dearborn 290
Des Moines 266
Hanover 263
Hangzhou 185
Jinan 154
Shenyang 139
Toronto 118
Nanchang 108
Chandler 105
Guangzhou 104
Hebei 102
Shanghai 101
San Diego 96
Tianjin 90
Changsha 89
Jacksonville 88
Zhengzhou 83
Phoenix 80
Taipei 77
Dong Ket 74
Tokyo 69
Mountain View 65
Redmond 60
Rome 56
Silver Spring 55
Central District 53
Jiaxing 53
Kunming 49
Seoul 49
Ottawa 47
Berlin 42
Istanbul 39
Lanzhou 37
Andover 36
Bogotá 35
Duncan 35
Falls Church 34
Fremont 31
Taiyuan 31
Haikou 30
Somerville 30
Athens 29
Sakarya 29
Fuzhou 28
Munich 26
Serra 26
Taizhou 25
Hefei 24
Ningbo 24
Chengdu 23
Jakarta 23
Wuhan 23
Changchun 22
Hanoi 22
Brussels 21
Mexico 20
Roxbury 20
Los Angeles 19
Napoli 19
New York 19
San Francisco 19
São Paulo 19
Norwalk 18
London 17
Xian 17
Margão 16
Sydney 16
Bologna 15
Mumbai 15
Zurich 14
Grafing 13
Rochester 13
Buffalo 12
Islamabad 12
Madrid 12
Palermo 12
Palo Alto 12
Petaling Jaya 12
Rho 12
Saint Petersburg 12
Singapore 12
Tegucigalpa 12
Bangkok 11
Brescia 11
Catania 11
Florence 11
Totale 15982
Nome #
Dietary treatment of urinary risk factors for renal stone formation : A review of CLU Working Group 1198
Rituximab as maintenance treatment for systemic Lupus Erythematosus: a multicentre observational study of 147 patients 458
Summary of the International Conference on Onco-Nephrology: an emerging field in medicine 429
Iperfosfatemia in dialisi: la scelta del chelante 370
Hepcidin levels in chronic hemodialysis patients : A critical evaluation 355
Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: A clinical observational study 347
IgM Autoantibodies to Complement Factor H in Atypical Hemolytic Uremic Syndrome 299
The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival 252
I nuovi farmaci antivirali per la terapia di HCV post- trapianto renale 238
Podocytes: Recent biomolecular developments 212
Farmaci ad azione antivirale diretta, epatite C e dialisi: un aggiornamento 208
Metabolic acidosis in renal transplantation: Neglected but of potential clinical relevance 189
VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey 187
HCV, HBV, HIV ed emodialisi 183
NeuroD Expression in Podocytes and Interrelationships with Nephrin at Both Nuclear and Cytoplasmic Sites 177
Natural history of hepatitis B and C in renal allograft recipients 174
The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients : TMPRSS6 and hepcidin in hemodialysis 167
HBV vaccination with Fendrix is effective and safe in pre-dialysis CKD population 162
FGF23 and Fetuin-A Interaction and Mesenchymal Osteogenic Transformation 159
La doppia borsa di tabacco intorno alla cuffia profonda del catetere peritoneale: una tecnica per l’inizio immediato della CAPD [Double purse-string craft around the inner cuff: a new technique for an immediate start of CAPD] 159
ERRATUM: Dietary treatment of urinary risk factors for renal stone formation : A review of CLU Working Group 158
End-stage renal disease costs for patients new to hemodialysis in Italy: The FARO-2 Study 156
Membranous Nephropathy (MN) Recurrence after Renal Transplantation 149
The long-term outcome of 93 patients with proliferative lupus nephritis 148
Pathophysiology of calcium and phosphate metabolism impairment in Chronic Kidney Disease 145
Vitamin K in Chronic Kidney Disease 145
How a skilful and motivated urinary sediment examination can save the kidneys 143
Long-term outcome of renal transplantation in patients with idiopathic membranous glomerulonephritis (MN) 137
Long-term evaluation of coronary artery calcifications in kidney transplanted patients : a follow up of 5 years 137
Discoidin domain receptor-1 and periostin: New players in chronic kidney disease 132
Pratica clinica per la diagnostica delle aritmie cardiache in pazienti in terapia renale sostitutiva: dati di una survey lombarda 130
Nuovi scenari nell’iperparatiroidismo secondario: etelcalcetide : Position Paper dei Nefrologi lombardi [New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of Nephrologists form Lombardy] 130
Effect of a home based, low intensity, physical exercise program in older adults dialysis patients: A secondary analysis of the EXCITE trial 128
Evaluating targets and costs of treatment for secondary hyperparathyroidism in incident dialysis patients: the FARO-2 study 126
Effect of VDRA on survival in incident hemodialysis patients: results of the FARO-2 observational study 123
Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial 122
Vitamin B12 status in patients with renal failure 119
Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients 117
Luminex technology for anti-HLA antibody screening : evaluation of performance and of impact on laboratory routine 113
A new approach for anemia in kidney disease 113
Early involvement of cellular stress and inflammatory signals in the pathogenesis of tubulointerstitial kidney disease due to UMOD mutations 113
Nutritional vitamin D in renal transplant patients : speculations and reality 112
Podocyte developmental defects caused by adriamycin in zebrafish embryos and larvae: A novel model of glomerular damage 111
Vitamin and oxidative status in patients with systemic lupus erythematosus 110
Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials 110
Renal transplantation in adults with Henoch-Schonlein purpura: long-term outcome 110
High-phosphate induced vascular calcification is reduced by iron citrate through inhibition of extracellular matrix osteo-chondrogenic shift in VSMCs 110
Ematuria che scompare in ospedale : una causa insolita 109
Achievement of NKF/K-DOQI recommended target values for bone and mineral metabolism in incident hemodialysis patients : results of the FARO-2 Cohort 109
Ruolo della valutazione della morfologia delle emazia urinarie (VMEU) in pazienti con microematuria isolata di origine sconosciuta (MIOS) 108
Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) 108
Pathophysiology of Non Alcoholic Fatty Liver Disease 108
Abnormal arachidonic acid content of red blood cell membranes and main lithogenic factors in stone formers 108
The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism 107
Malignancies in 2753 kidney recipients transplanted during a 39-year experience 106
Behaviour of phosphate removal with different dialysis schedules 106
Sarcopenia is Associated with Malnutrition but Not with Systemic Inflammation in Older Persons with Advanced CKD 106
The role of immunosuppression in malignancies among 351 pediatric renal transplant patients 104
Impact of the method of calculation on assessment of the PTH-calcium set point 104
Physical performance and clinical outcomes in dialysis patients: A secondary analysis of the excite trial 103
FGF23 and vascular calcifications: Another piece of the puzzle? 102
FGF23 and Fetuin-A interaction in the liver and in the circulation 102
A randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism 102
ANCA-associated vasculitis with renal involvement 101
Therapeutic Effect of Iron Citrate in Blocking Calcium Deposition in High Pi-Calcified VSMC: Role of Autophagy and Apoptosis 101
The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy 100
Antiviral Therapy for HCV-Associated Cryoglobulinemic Glomerulonephritis : Case Report and Review of the Literature 100
Impact of HCV and Direct Acting Antivirals on Kidney Recipients: a retrospective study 99
Uremic Patients with Increased Vascular Calcification Score Have Serum with High Calcific Potential : Role of Vascular Smooth Muscle Cell Osteoblastic Differentiation and Apoptosis 99
Native Hypovitaminosis D in CKD Patients : From Experimental Evidence to Clinical Practice 99
Gut microbiota composition and frailty in elderly patients with Chronic Kidney Disease 99
Secondary hyperparathyroidism in chronic dialysis patients : results of the Italian FARO survey on treatment and mortality 98
Hepatorenal syndrome and novel advances in its management 96
Functional renal involvement in normotensive patients with progressive systemic sclerosis: impaired sodium excretion during isotonic saline infusion 96
Genetic factors and iron-related oxidative stress influence serum ferritin, associated with cardiovascular damage and mortality, in hemodialysis patients 95
Carotid plaques in patients with long-term lupus nephritis 95
NGAL as a renal injury marker : a prospective trial using Wolf Piezolith 3000 94
HFE gene mutations and oxidative stress influence serum ferritin, associated with vascular damage, in hemodialysis patients 93
Hepatic disorders in chronic kidney disease 93
Skin infection due to Alternaria species in kidney allograft recipients: report of a new case and review of literature 92
ADPKD : clinical issues before and after renal transplantation 91
Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): Planted antigens 91
FGF23-regulated production of Fetuin-A (AHSG) in osteocytes 91
Use of the Frailty Index in Older Persons with Chronic Kidney Disease 91
Direct in vivo assessment of parathyroid hormone-calcium relationship curve in renal patients 91
The long-term prognosis of renal transplantation in patients with lupus nephritis 90
Urine erythrocyte morphology in patients with microscopic haematuria caused by a glomerulopathy 90
Haploidentical Hematopoietic Stem Cell Transplant Complicated by Atypical Hemolytic Uremic Syndrome and Kidney Transplant from the Same Donor with No Immunosuppression but C5 Inhibition 90
Kinetics of hepatitis B virus load during haemodialysis sessions and α-interferon: A prospective study 90
Immunoglobulin A Nephropathy. Recurrence After Renal Transplantation 89
Acute tubular necrosis following interferon-based therapy for hepatitis C : case study with literature review 88
Recombinant Hepatitis B Vaccine Adjuvanted With AS04 in Dialysis Patients: A Prospective Cohort Study 87
Persistent secondary hyperparathyroidism after renal transplantation 87
What can we learn from a statistically inconclusive trial? Consensus conference on the EVOLVE study results 86
Meta-analysis: the impact of diabetes mellitus on the immunological response to hepatitis B virus vaccine in dialysis patients 86
HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients 86
Erythropoietin Use and Immunogenicity of Hepatitis B Virus Vaccine in Chronic Kidney Disease Patients: A Meta-Analysis 86
Calcium and Phosphate Control by Dialysis Treatments 85
Calcimimetic increases osteoprotegerin and decreases fetuin-A levels in dialysis patients 85
Clinical impact of hypercalcemia in kidney transplant 85
Totale 14477
Categoria #
all - tutte 29012
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29012


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20181012 09498136 70107 9480 676512873
2018/20194056 268103598414 142172 615223 349360430382
2019/20207114 933259302704 4511069 711552 862613328330
2020/20215348 421356439309 464553 320554 484502505441
2021/20224967 426237234349 337365 605330 398429363894
2022/2023687 57311400 00 00 0000
Totale 24651